Unicycive Therapeutics (UNCY) Enterprise Value (2021 - 2026)
Unicycive Therapeutics (UNCY) reported Enterprise Value of $69.22 million for Q2 2026, up 53.9% from $44.99 million a year earlier but down 37.9% from the prior quarter.
Unicycive Therapeutics (UNCY) Enterprise Value (2021 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Unicycive Therapeutics' Enterprise Value came in at -$69.33 million; for FY2025, it was $50.4 million, up 86.4% from FY2024.
- Enterprise Value has increased for four consecutive years, with a four-year compound annual growth rate of 61.1% (FY2021 to FY2025).
- By year, Enterprise Value came in at $27.04 million in FY2024 (+133.2%), $11.6 million in FY2023 (+49.3%), $7.77 million in FY2022 (+4.0%) and $7.47 million in FY2021.
- Five-year quarterly Enterprise Value spans a low of -$19.95 million in Q2 2024 and a high of $111.48 million in Q1 2026.
- Year over year, Enterprise Value has now increased in each of the last four quarters, with growth averaging 147.6% over the last six quarters.
- The high point for year-over-year Enterprise Value in five years was Q3 2023 (growth of 721.6%); the low point was Q3 2022 (a decline of 92.2%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $111.48 million (Q1 2026), $50.4 million (Q4 2025) and $48.21 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn |
| 10 | Unicycive Therapeutics | 104.17 Mn | -95.81 Mn | - |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 69.22 Mn |
| Mar 31, 2026 | 111.48 Mn |
| Dec 31, 2025 | 50.40 Mn |
| Sep 30, 2025 | 48.21 Mn |
| Jun 30, 2025 | 44.99 Mn |
| Mar 31, 2025 | 49.09 Mn |
| Dec 31, 2024 | 27.04 Mn |
| Sep 30, 2024 | 7.58 Mn |
| Jun 30, 2024 | -19.95 Mn |
| Mar 31, 2024 | 2.97 Mn |
| Dec 31, 2023 | 11.60 Mn |
| Sep 30, 2023 | 15.54 Mn |
| Jun 30, 2023 | 684,105.89 |
| Mar 31, 2023 | 7.66 Mn |
| Dec 31, 2022 | 7.77 Mn |
| Sep 30, 2022 | 1.89 Mn |
| Jun 30, 2022 | 1.91 Mn |
| Mar 31, 2022 | 5.76 Mn |
| Dec 31, 2021 | 7.47 Mn |
| Sep 30, 2021 | 24.36 Mn |
Unicycive Therapeutics Enterprise Value API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=enterprise-value&ticker=UNCY&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "enterprise-value", "ticker": "UNCY", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=enterprise-value&ticker=UNCY&period=max&api_key=YOUR_API_KEY");
const data = await res.json();